Table 3 Risk assessment of serum leptin in study participants
From: Adipocytokines in obese Ghanaian subjects with or without type 2 diabetes
Variable | OR | p-value | 95% CI | aOR | p-value | 95% CI |
|---|---|---|---|---|---|---|
Diabetics | ||||||
Non-diabetics | 3.315 | < 0.0001 | 1.918–5.824 | 3.217 | < 0.0001 | 1.008–6.045 |
Gender | ||||||
Male | ||||||
Female | 9.750 | < 0.0001 | 4.461–21.311 | 9.561 | < 0.0001 | 4.060–24.200 |
Exercise | ||||||
Yes | ||||||
No | 1.296 | 0.466 | 0.646–2.600 | 1.245 | 0.566 | 0.588–2.636 |
Viceral fats | ||||||
< 9.0 | ||||||
> 9.0 | 0.163 | 0.090 | 0.020–1.330 | 0.223 | 0.176 | 0.025–1.962 |
Family history of DM | ||||||
No | ||||||
Yes | 0.655 | 0.211 | 0.338–1.270 | 1.018 | 0.962 | 0.490–2.114 |
TCHOL | ||||||
3.5–6.5 mmol/L | ||||||
> 6.5 mmol/l | 1.453 | 0.671 | 0.259–8.157 | 0.819 | 0.83 | 0.132–5.094 |
TG | ||||||
1.7–2.2 mmol/L | ||||||
> 2.2 mmol/l | 0.711 | 0.737 | 0.098–5.163 | 1.041 | 0.97 | 0.128–6.477 |
HDL | ||||||
1.3–1.5 mmol/L | ||||||
> 1.5 mmol/l | 1.835 | 0.476 | 0.346–3.739 | 1.764 | 0.532 | 0.298–4.434 |
LDL | ||||||
3.37–4.12 mmol/L | ||||||
> 4.12 mmol/l | 0.685 | 0.428 | 0.269–1.746 | 0.418 | 0.099 | 0.148–1.179 |